Home >> Zedong Alton (page 129)

Zedong Alton

Alton Zedong is an experienced Market Research, Customer Insights & Consulting professional, covering latest industry and market updates on Electronics, Semiconductor and ICT domain.

Asthma research and market – Identifying and Commercializing First-in-Class Innovation

Large and Innovative Pipeline Analysis has confirmed the asthma pipeline to be highly active, with 252 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations is significant. Research analysis identified 59 ...

Read More »

Rheumatoid Arthritis Therapeutics in Asia-Pacific Market is expected to register at a CAGR of 3.3% by 2021

Research, the leading business intelligence provider, has released its latest research, “”Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 – Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs””, which provides in-depth analysis of Rheumatoid Arthritis (RA) market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The ...

Read More »

Global Contract Research Organization(CRO) Market size,share, trends, growth, analysis, industry research report, Deals and Operational Strategies

Research’s latest report “Contract Research Organization Market: Global Deals and Operational Strategies” discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key players in the recent years have been listed. A heatmap analysis of the key companies was ...

Read More »

Global Research on Pancreatic Cancer – Identifying and Commercializing First-in-Class Innovation: Market size, share, trends, growth and analysis report

Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not being met by the current market. A highly active pancreatic cancer pipeline ...

Read More »

Analyst’s Predicts Rheumatoid Arthritis Market Expected to grow at a CAGR of 5.2% by 2020 – A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands and feet, which hinders patient mobility. Without treatment, the disease leads to joint destruction and disability. Prior to 1998, ...

Read More »

Colorectal Cancer (CRC) Therapeutics Market will grow at a CAGR of 5% by 2020

Research, the leading business intelligence provider, has released its latest research: “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 – Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in the eight major geographies of the US, Canada, the UK, France, Germany, Spain, Italy and ...

Read More »

Ovarian Cancer Therapeutics in Asia-Pacific Market revenue is forecast to rise at a limited CAGR of 5.1% by 2020

Research, a leading business intelligence provider, has released its latest research report: “Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 – Off-patent Chemo-regimens to Retain Dominance Despite New Launches”. The report provides estimates of the market size for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, China, Australia and Japan. It also covers disease epidemiology, treatment ...

Read More »